Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥343.3B | ¥321.9B | +6.6% |
| Operating Income | ¥60.2B | ¥49.9B | +20.7% |
| Ordinary Income | ¥62.3B | ¥52.0B | +19.9% |
| Net Income | ¥42.5B | ¥36.4B | +16.7% |
| ROE | 8.5% | 7.7% | - |
Executive Summary
This was a financial period in which profitability improved as profit growth outpaced revenue growth. Revenue was ¥343.3B (+6.6% YoY), Operating Income was ¥60.2B (+20.7%), Ordinary Income was ¥62.3B (+19.9%), and Net Income attributable to owners of the parent was ¥42.5B (+16.7%). The Operating Income margin improved by approximately 2.1pt from the same period of the previous year to 17.5%, with margin expansion, in addition to the positive effect of higher revenue, driving profit growth.
Factors Affecting Financial Performance
[Revenue] Revenue was ¥343.3B (+6.6% YoY). By segment, Abrasives served as the earnings pillar, generating ¥165.3B in revenue (48.2% composition ratio, 27.9% Operating Income margin), while Chemical Industry Products remained at ¥107.0B (31.2% composition ratio, 10.3% Operating Income margin). Combined revenue from the two segments was ¥272.3B, and growth in both segments supported company-wide revenue growth.
[Profit and Loss] Gross profit margin was 36.7%, the SG&A expense ratio was 19.1%, and the Operating Income margin was 17.5%, expanding by approximately 2.1pt from approximately 15.5% in the same period of the previous year. Non-operating income and expenses consisted of income of ¥3.7B, including dividend income of ¥0.96B, and expenses of ¥1.6B; Ordinary Income therefore increased generally in line with Operating Income. Extraordinary losses of ¥2.8B, including impairment losses of ¥1.7B, reduced Profit Before Tax, but growth in recurring business income was the primary driver of higher Net Income. Revenue and profit both increased.
Segment Analysis
The Abrasives segment maintained high profitability, with revenue of ¥165.3B, Operating Income of ¥46.2B, and a margin of 27.9%, accounting for the majority of company-wide Operating Income. The Chemical Industry Products segment generated revenue of ¥107.0B, Operating Income of ¥11.1B, and a margin of 10.3%, remaining less profitable than Abrasives. The high margin of the Abrasives segment drives up the company-wide Operating Income margin of 17.5%.
Key Financial Metrics
[Profitability] The Operating Income margin of 17.5% and Net Income margin of 12.4% both improved from the same period of the previous year (approximately 15.5% and approximately 11.3%, respectively). ROE was 8.5%; relative to the high Net Income margin, the Total Asset Turnover ratio of 0.49x is a constraining factor. [Cash Quality] Non-operating income remained at only 1.1% of revenue, indicating a high level of earnings quality; however, the collection period for accounts receivable of ¥86.7B was relatively long at 69 days on an annualized basis, while work in process of ¥25.4B accounted for 44.2% of manufacturing inventories, indicating a biased inventory composition. [Investment Efficiency] The Total Asset Turnover ratio was 0.49x, and property, plant and equipment accounted for 56.4% of total assets, representing a capital-intensive structure with room to improve asset efficiency. [Financial Soundness] The Equity Ratio was 71.7%, the Current Ratio was 196.4%, and cash and deposits of ¥90.1B were approximately 11.8x short-term borrowings of ¥7.6B, indicating an extremely stable financial foundation.
Cash Flow Analysis
Although the statement of cash flows has not been disclosed, funding trends can be assessed from the balance sheet and profit structure. Operating Income of ¥60.2B and Net Income of ¥42.5B are characterized by low dependence on non-operating income and are derived primarily from the core business. Meanwhile, accounts receivable of ¥86.7B corresponded to 69 days on an annualized DSO basis, and work in process of ¥25.4B accounted for 44.2% of manufacturing inventories; therefore, fluctuations in working capital could affect the conversion of earnings into cash. Cash and deposits amounted to ¥90.1B, increasing from the previous year. Together with an Equity Ratio of 71.7% and a Current Ratio of 196.4%, this indicates that sufficient financial capacity has been secured to absorb such working capital fluctuations.
Quality of Earnings
The quality of Current Period Net Income of ¥42.5B is generally sound. Non-operating income of ¥3.7B amounted to only 1.1% of revenue and consisted primarily of dividend income of ¥0.96B, indicating low dependence on financial income. Extraordinary income of ¥0.2B (gain on sale of fixed assets) and extraordinary losses of ¥2.8B (including impairment losses of ¥1.7B) were recorded, creating a temporary factor that reduced Profit Before Tax by ¥2.5B. Excluding the impairment loss, growth in recurring business income was the central driver of profit growth. Comprehensive Income of ¥49.0B exceeded Net Income of ¥42.5B, primarily due to an increase of ¥5.8B in valuation difference on securities; this does not indicate a divergence from the underlying business performance.
Earnings Forecasts and Guidance
The full-year plan calls for revenue of ¥454.0B (+5.8% YoY), Operating Income of ¥75.0B (+15.8%), and Ordinary Income of ¥77.0B (+15.4%). The Q3 cumulative progress ratios were 75.6% for revenue, 80.3% for Operating Income, and 80.9% for Ordinary Income, exceeding the standard 75% level. However, achieving the full-year plan requires a Q4 Operating Income margin of approximately 13.3%. Since this is below the cumulative actual margin of 17.5%, the plan incorporates a slowdown in profitability toward the end of the fiscal year.
Shareholder Returns
The Q2 dividend was ¥75.00 per share, and the full-year forecast dividend is ¥160.00 (a plan to increase the dividend from the previous year’s actual dividend of ¥60). The simple Payout Ratio against Q3 cumulative Net Income is 20.0%, while the forecast annual Payout Ratio calculated based on the full-year Net Income forecast of ¥50.0B and the number of shares outstanding is approximately 36.3%. Retained earnings of ¥384.0B and an Equity Ratio of 71.7% provide substantial financial capacity, creating a solid foundation supporting the sustainability of dividend payments.
Risk Factors
-
Accounts Receivable Collection Risk: Accounts receivable of ¥86.7B corresponds to 69 days on an annualized DSO basis, exceeding the general benchmark of 45 days. Prolonged collection terms and the financial conditions of business partners could affect working capital and the conversion of earnings into cash.
-
Work-in-Process Accumulation Risk: Work in process of ¥25.4B accounts for 44.2% of total manufacturing inventories, exceeding the 40% level. Prolonged production processes or fluctuations in demand could affect inventory valuation and production efficiency.
-
Fixed Asset Impairment Risk: An impairment loss of ¥1.7B was recorded in the current period. Property, plant and equipment account for 56.4% of total assets, representing a capital-intensive structure; additional impairment could occur if the profitability of individual assets continues to decline.
Industry Benchmarks (For Reference; Compiled by the Company)
Industry Benchmarks (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income Margin | 17.5% | 8.6% (4.3%–12.7%) | +8.9pt |
| Net Income Margin | 12.4% | 6.4% (2.8%–10.3%) | +6.0pt |
Both the Operating Income margin and Net Income margin significantly exceed the industry median, indicating an advantageous level of profitability within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 6.6% | 3.3% (-2.1%–8.9%) | +3.3pt |
The revenue growth rate also exceeds the industry median, but remains within the upper bound of the IQR (8.9%) and is not at an exceptional level.
Source: Compiled by the Company
Key Takeaways from the Financial Results
-
The Operating Income margin of 17.5% and Net Income margin of 12.4% are both strong relative to industry comparisons and the previous year, with margin improvement from the same period of the previous year continuing.
-
Progress toward the full-year plan is 80.3% for Operating Income and 85.1% for Net Income, exceeding standard progress levels. However, the plan assumes that the Q4 margin will be below the cumulative actual margin, making demand and cost trends at the end of the fiscal year key areas of focus.
-
Despite the high level of financial soundness, with an Equity Ratio of 71.7% and cash and deposits at 11.8x short-term borrowings, ROE of 8.5% is constrained by a Total Asset Turnover ratio of 0.49x, indicating room for improvement in capital efficiency.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥4,461 |
| base | ¥4,611 |
| bull | ¥4,675 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥4,464 |
| Adjusted Forecast EPS | ¥487.8 |
| Cost of Equity r | 9.77% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 36.1% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on progress ahead of the full-year forecast) |
| Implied PBR / PER | 1.03x / 9.5x |
Sensitivity: ¥4,483–¥4,745 at ±1% in the cost of equity, and ¥4,608–¥4,616 at ω±0.1.
Notes:
- Since Net Income progress against the full-year forecast (85%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of plan tend to outperform forecasts. For businesses with strong seasonality, the adjustment may be excessive).
- Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
- Since net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional adviser as necessary.
---End of Report---